Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$172,548
-$7,849 QoQ
Shares Held
1,101
-6.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,330
of 1,603 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SBI Securities Co., Ltd. holds $85,291,316 across 16 Drug Manufacturers - General names. NVS ranks #13 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
112,391 | $28,543,942 | |
| 2 | ABBV |
AbbVie Inc.
|
61,053 | $15,363,376 | |
| 3 | PFE |
Pfizer Inc
|
623,853 | $15,022,380 | |
| 4 | LLY |
ELI LILLY & Co
|
12,333 | $14,792,571 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,631 | $2,394,083 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
18,046 | $2,279,931 | |
| 7 | GSK |
GSK plc
|
36,393 | $1,907,721 | |
| 8 | NVO |
Novo Nordisk A S
|
27,582 | $1,322,281 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $172,548 | 1,101 | Shares | Defined | 2026-07-23 | |
| 2026-03-31 | $180,397 | 1,181 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $170,269 | 1,235 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $809,579 | 6,313 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $65,829 | 544 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $127,867 | 1,147 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $96,628 | 993 | Shares | Defined | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||